Vaccine Therapy in Treating Patients With Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Liver Cancer
Related studies linked through entity extraction aliases.
Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
SCH 66336 With or Without Gemcitabine Followed by Surgery Compared With Surgery Alone in Treating Patients With Primary Liver Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Chronic Thalidomide Administration in Patients Undergoing Chemoembolization for Unresectable Hepatocellular Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed
- Status
- COMPLETED
- Phase
- PHASE2
Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer
- Status
- TERMINATED
- Phase
- PHASE2
DX-8951f in Treating Patients With Biliary Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Therapy in Treating Patients With Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Biological Therapy in Treating Patients With Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2